Previous 10 | Next 10 |
2024-06-05 11:46:27 ET Summary Mind Medicine's (MindMed) results from phase 1 investigator-initiated trial, using MM-402 for the treatment of patients with Autism Spectrum Disorder, expected Q2 of 2024. The primary endpoint of the phase 2b MMED008 study met with statistical signif...
2024-06-05 10:14:00 ET More on etc. Gold: Reversal Signals Are Increasing Ares Capital: Another Strong Quarter Despite A Decline In Net Income Regency Centers: Ongoing FFO Growth Can Lift Shares If Interest Rates Stop Rising AbbVie doses first patient in phas...
2024-06-05 07:17:36 ET More on ATAI, COMPASS Pathways, etc. ATAI: Enormous Potential Upside But No Clarity Yet Psychedelics Closer To Commercialization; Compass Far And Away The Leader COMPASS Pathways plc (CMPS) Q1 2024 Earnings Call Transcript Biggest stock...
2024-06-05 05:01:50 ET More on related stocks: CrowdStrike: Record-Breaking Q1 Earnings, My Thoughts On Valuation CrowdStrike Holdings, Inc. (CRWD) Q1 2025 Earnings Call Transcript Hewlett Packard Enterprise Company (HPE) Q2 2024 Earnings Call Transcript Crow...
2024-06-04 17:32:04 ET More on psychedelic drug companies ATAI: Enormous Potential Upside But No Clarity Yet Psychedelics Closer To Commercialization; Compass Far And Away The Leader COMPASS Pathways plc (CMPS) Q1 2024 Earnings Call Transcript Psychedelic sto...
2024-06-04 10:47:04 ET Shoals Technologies Group Inc (SHLS) SHLS is trading DOWN for the last 4 days, and it at trading at $7.15 with volume of 1,279,083 and a one day change of $-0.02 (-0.21%). Shoals Technologies Group Inc has a 52-week low of 6.29 and a 52-week high of $28.34. Th...
2024-05-31 10:43:44 ET More on ATAI, COMPASS Pathways, etc. ATAI: Enormous Potential Upside But No Clarity Yet Psychedelics Closer To Commercialization; Compass Far And Away The Leader COMPASS Pathways plc (CMPS) Q1 2024 Earnings Call Transcript Mind Medicine...
2024-05-30 15:54:21 ET The Russell 3000 index will have a new look on June 28, after the market closes, when 225 securities will be added and 144 securities will be deleted as part of the annual reconstitution. Following are some notable healthcare companies which will be added and ...
The state of Colorado is pioneering the way once more as government leaders figure out how to establish and regulate the nascent psychedelics industry. The state was the first to legalize the recreational use of marijuana. This latest move comes after Colorado became one of the first states i...
2024-05-29 09:29:04 ET More on Mind Medicine MindMed releases promising phase 2 data on LSD-related anxiety therapy MindMed: Breakthrough Status From The FDA For LSD Therapy Psychedelics Closer To Commercialization; Compass Far And Away The Leader Mind Medici...
News, Short Squeeze, Breakout and More Instantly...
Mind Medicine (MindMed) Inc. Company Name:
MNMD Stock Symbol:
NASDAQ Market:
Mind Medicine (MindMed) Inc. Website:
The University of Colorado Denver recently launched the CU Denver Center for Psychedelic Research. This center is focused on improving the quality of life of individuals by conducting research on the potential benefits psychedelics may possess in the treatment of various mental, neurological, e...
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced today that as part of the annual reconstitution of the Russell stock indexes, the Company will...
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that members of the Company’s management team will present a...